194 related articles for article (PubMed ID: 31102172)
1. Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells.
Herrera-Martínez AD; Feelders RA; de Herder WW; Castaño JP; Gálvez Moreno MÁ; Dogan F; van Dungen R; van Koetsveld P; Hofland LJ
Horm Cancer; 2019 Jun; 10(2-3):107-119. PubMed ID: 31102172
[TBL] [Abstract][Full Text] [Related]
2. Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
Herrera-Martínez AD; van den Dungen R; Dogan-Oruc F; van Koetsveld PM; Culler MD; de Herder WW; Luque RM; Feelders RA; Hofland LJ
Endocr Relat Cancer; 2019 Jun; 26(6):585-599. PubMed ID: 30939452
[TBL] [Abstract][Full Text] [Related]
3. Ketoconazole Treatment Decreases the Viability of Immortalized Pituitary Cell Lines Associated with an Increased Expression of Apoptosis-Related Genes and Cell Cycle Inhibitors.
Guzzo MF; Carvalho LR; Bronstein MD
J Neuroendocrinol; 2015 Jul; 27(7):616-23. PubMed ID: 25808816
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.
Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG
Front Endocrinol (Lausanne); 2021; 12():793262. PubMed ID: 35058882
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells.
Herrera-Martínez AD; Feelders RA; Van den Dungen R; Dogan-Oruc F; van Koetsveld PM; Castaño JP; de Herder WW; Hofland LJ
Neuroendocrinology; 2020; 110(5):351-363. PubMed ID: 31319410
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of TPIT expression in ACTH-secreting extra-pituitary neuroendocrine tumors (NETs) supports the existence of different cellular programs in pancreatic and pulmonary NETs.
Uccella S; Leoni E; Kaiser S; Maragliano R; Valerio A; Libera L; Tanda ML; Volante M; Diviani D; La Rosa S
Virchows Arch; 2023 Nov; 483(5):635-643. PubMed ID: 37726450
[TBL] [Abstract][Full Text] [Related]
7. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
[TBL] [Abstract][Full Text] [Related]
8. Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
Mohamed A; Blanchard MP; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Monges G; Garcia S; Ferone D; Florio T; Enjalbert A; Moutardier V; Schonbrunn A; Gerard C; Barlier A; Saveanu A
Endocr Relat Cancer; 2014 Oct; 21(5):691-704. PubMed ID: 25012983
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.
Zhang C; Jin J; Xie J; Ye L; Su T; Jiang L; Zhou W; Jiang Y; Wu L; Wang T; Zhong X; Ning G; Shen B; Wang W
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785672
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
11. Ectopic ACTH syndrome.
Wajchenberg BL; Mendonça B; Liberman B; Adelaide M; Pereira A; Kirschner MA
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):139-51. PubMed ID: 7626446
[TBL] [Abstract][Full Text] [Related]
12. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion from a Meckel diverticulum neuroendocrine tumor: case report.
Paun DL; Vija L; Stan E; Banica A; Bobeica E; Terzea D; Poiana C; Badiu C; Paun S
BMC Endocr Disord; 2015 Nov; 15():72. PubMed ID: 26610855
[TBL] [Abstract][Full Text] [Related]
13. Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene.
Tateno T; Kato M; Tani Y; Yoshimoto T; Oki Y; Hirata Y
J Endocrinol Invest; 2010 Feb; 33(2):113-7. PubMed ID: 19786827
[TBL] [Abstract][Full Text] [Related]
14. Antisecretory Effects of Chimeric Somatostatin/Dopamine Receptor Ligands on Gastroenteropancreatic Neuroendocrine Tumors.
Couvelard A; Pélaprat D; Dokmak S; Sauvanet A; Voisin T; Couvineau A; Ruszniewski P
Pancreas; 2017; 46(5):631-638. PubMed ID: 28375946
[TBL] [Abstract][Full Text] [Related]
15. The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Nölting S; Rentsch J; Freitag H; Detjen K; Briest F; Möbs M; Weissmann V; Siegmund B; Auernhammer CJ; Aristizabal Prada ET; Lauseker M; Grossman A; Exner S; Fischer C; Grötzinger C; Schrader J; Grabowski P;
PLoS One; 2017; 12(8):e0182852. PubMed ID: 28800359
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 increases intracellular calcium concentration in human primary neuroendocrine pancreatic tumor cells and a pancreatic neuroendocrine tumor cell line (BON-1) via R-type Ca2+ channels and regulates chromogranin a secretion in BON-1 cells.
Mergler S; Strauss O; Strowski M; Prada J; Drost A; Langrehr J; Neuhaus P; Wiedenmann B; Ploeckinger U
Neuroendocrinology; 2005; 82(2):87-102. PubMed ID: 16424676
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro.
Somnay Y; Chen H; Kunnimalaiyaan M
Neuroendocrinology; 2013; 97(2):183-92. PubMed ID: 22965070
[TBL] [Abstract][Full Text] [Related]
19. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
Zhou YZ; Li CZ; Gao H; Zhang YZ
World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
